<DOC>
	<DOC>NCT01758354</DOC>
	<brief_summary>The purpose of this study is to test the feasibility of a newborn screen assay for Pompe disease</brief_summary>
	<brief_title>Newborn Screening Assay of Pompe's Disease</brief_title>
	<detailed_description>DBS from newborn will be tested for acid alpha-glucosidase (GAA) activity. Babies with low GAA activity will be confirmed for Pompe disease.</detailed_description>
	<mesh_term>Glycogen Storage Disease Type II</mesh_term>
	<criteria>newborns receiving newborn screening in Newborn Screening center of National Taiwan Univeristy Hospital parents signed inform consent for this study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Pompe disease</keyword>
	<keyword>alpha glucosidase deficiency</keyword>
</DOC>